Article
Prevalence and impact of hepatic steatosis on the response to antiviral therapy in Saudi patients with genotypes 1 and 4 chronic hepatitis C.
Digestive diseases and sciences - 1 Apr 2011
AlQaraawi Abdallah M, Sanai Faisal M, Al-Husseini Hussa, Albenmousa Ali, AlSheikh Abdulmalik, Ahmed Lubna Rizwan, Hersi Ahmad, Al-Otaibi Molfi M, Syed Mohammed, Ali Safiyya M, Al-hamoudi Waleed, Alswat Khalid A, Abdo Ayman A
Abstract excerpt
BACKGROUND: Hepatic steatosis in hepatitis C virus (HCV)-infected patients has been shown to enhance the progression of liver fibrosis and decrease the response to antiviral therapy. AIMS: We aimed to determine the role of HCV genotype 4 (HCV-G4) in the prevalence of hepatic steatosis, its impact on antiviral therapy, and its associations and predictive factors in comparison to HCV-G1-infected patients. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.